OHSU researchers identify promising next-generation cancer

$ 21.00

4.8
(678)
In stock
Description

Chemistry discovery points to next generation inhibitors of PARP-1, a critical target in ovarian, breast and prostate cancers.

OHSU Knight Cancer Institute offers the latest treatments, technologies, hundreds of research studies and clinical trials

Latest Cell Culture News, Articles, Page 300

Department News

OHSU researchers identify promising next-generation cancer treatment

The Next Cancer Breakthroughs - Cancer Health

IJMS August-1 2023 - Browse Articles

Research OHSU News

Stories OHSU News

Search OHSU News

Oregon flirts with—and quickly abandons—plan to deny Medicaid payment for next-generation sequencing - The Cancer Letter

MRI innovation for the first time reveals cells' energy activity in organs and tissues

OHSU attracts nearly $600 million in research funding — a record

Staci Silber Crane on LinkedIn: OHSU researchers identify promising next-generation cancer treatment